Association between Individual Characteristics and Long COVID Severity among COVID-19 Survival in Jabodetabek
Article Sidebar
Main Article Content
Abstract
Long COVID has a prevalence of between 10 and 30 percent in patients with a history of SARS-CoV-2 infection and has different levels of symptom severity. This study aimed to determine the individual characteristics based on age and sex along with the severity of Long COVID in Jabodetabek. This study used a cross-sectional design and purposive sampling technique to determine the sample size. The inclusion criteria were COVID survivors who lived in Jabodetabek and had been exposed to COVID-19 based on examination by health workers. Furthermore, the analysis carried out in this study consisted of univariate and bivariate analyses. Data collection was collected online via social media using the Post (Long) COVID-19 Syndrome Questionnaire. The Chi- square statistical test results showed that of 399 respondents, there was a statistically significant relationship between gender and the severity of Long COVID, and women were 1.6 times more at risk of experiencing more severe Long COVID-19 symptoms than men. In addition, all symptoms such as fatigue, shortness of breath, chest pain, sleep disturbances, headaches, muscle aches, anosmia, dry cough, and concentration disorders are related to the severity of long COVID. The severity level based on sex and gender in this study could be used as the basis for providing intervention and prevention of COVID-19 according to the needs of each individual's body so that the proper intervention can help reduce the severity and control of COVID-19
Downloads
Article Details
Copyright (c) 2022 Siti Li'wuliyya, Widaad Camilah, Etis Setiawati, Hoirun Nisa
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Akbarialiabad, H., Taghrir, M. H., Abdollahi, A., Ghahramani, N., Kumar, M., Paydar, S., Razani, B., Mwangi, J., Asadi-Pooya, A. A., & Malekmakan, L. (2021). Long COVID, a comprehensive systematic scoping review. Infection, 1–24.
Asadi-Pooya, A. A., Akbari, A., Emami, A., Lotfi, M., Rostamihosseinkhani, M., Nemati, H., Barzegar, Z., Kabiri, M., Zeraatpisheh, Z., & Farjoud-Kouhanjani, M. (2021). Risk factors associated with long COVID syndrome: a retrospective study. Iranian Journal of Medical Sciences, 46(6), 428.
Asy’ari, Y. (2022). FAKTOR-FAKTOR YANG BERHUBUNGAN DENGAN KEJADIAN LONG COVID PADA PENINTAS COVID-19. Jurnal Fisioterapi Dan Kesehatan Indonesia, 2(1), 61– 69.
Bai, F., Tomasoni, D., Falcinella, C., Barbanotti, D., Castoldi, R., Mulè, G., Augello, M., Mondatore, D., Allegrini, M., & Cona, A. (2022). Female gender is associated with long COVID syndrome: a prospective cohort study. Clinical Microbiology and Infection, 28(4), 611-e9.
Brodin, P. (2021). Immune determinants of COVID-19 disease presentation and severity. Nature Medicine, 27(1), 28–33.
Buonsenso, D., Munblit, D., De Rose, C., Sinatti, D., Ricchiuto, A., Carfi, A., & Valentini, P. (2021). Preliminary evidence on long COVID in children. Acta Paediatrica (Oslo, Norway: 1992), 110(7), 2208.
Fernández-de-Las-Peñas, C., Martín-Guerrero, J. D., Pellicer-Valero, Ó. J., Navarro-Pardo, E., Gómez- Mayordomo, V., Cuadrado, M. L., Arias-Navalón, J. A., Cigarán-Méndez, M., Hernández- Barrera, V., & Arendt-Nielsen, L. (2022). Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the LONG-COVID-EXP-CM multicenter study. Journal of Clinical Medicine, 11(2), 413.
Garg, M., Maralakunte, M., Garg, S., Dhooria, S., Sehgal, I., Bhalla, A. S., Vijayvergiya, R., Grover, S., Bhatia, V., & Jagia, P. (2021). The conundrum of ‘long-COVID-19: a narrative review. International Journal of General Medicine, 2491–2506.
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., & Zhou, X. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet, 397(10270), 220–232.
Kamal, M., Abo Omirah, M., Hussein, A., & Saeed, H. (2021). Assessment and characterisation of post‐COVID‐19 manifestations. International Journal of Clinical Practice, 75(3), e13746.
Kementerian, P. P. N. (n.d.). Bappenas.(2021). Proyeksi COVID-19 di Indonesia.
Lemeshow, S., Hosmer, D. W., Klar, J., Lwanga, S. K., & Organization, W. H. (1990). Adequacy of
sample size in health studies. Chichester: Wiley.
Ludvigsson, J. F. (2021). Case report and systematic review suggest that children may experience similar
long‐term effects to adults after clinical COVID‐19. Acta Paediatrica, 110(3), 914–921.
Mińko, A., Turoń-Skrzypińska, A., Rył, A., Tomska, N., Bereda, Z., & Rotter, I. (2022). Searching for factors influencing the severity of the symptoms of long COVID. International Journal of Environmental Research and Public Health, 19(13), 8013.
Neng, R., Novia, N., Nova, A., Rahmi, A., Novita, S., Rima, N., Nirwanti, N., Rahman, N., Yuda, G., & Junaedi, J. (2020). Penyuluhan Tentang Senam Hipertensi Di Kp. Sukadanuh RT02 RW10 Desa Linggamukti Kecamatan Sucinaraja. Jurnal Pengabdian Masyarakat Dalam Kesehatan, 2(2), 26– 28.
Organization, W. H. (2022). COVID-19 weekly epidemiological update, edition 108, 7 September 2022.
Orrù, G., Bertelloni, D., Diolaiuti, F., Mucci, F., Di Giuseppe, M., Biella, M., Gemignani, A., Ciacchini, R., & Conversano, C. (2021). Long-COVID syndrome? A study on the persistence of neurological, psychological and physiological symptoms. Healthcare, 9(5), 575.
Ortona, E., & Malorni, W. (2022). Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. In European respiratory journal (Vol. 59, Issue 2). Eur Respiratory Soc.
Ozgocer, T., Dagli, Ş. N., Ceylan, M. R., Disli, F., Ucar, C., & Yildiz, S. (2022). Analysis of long‐term antibody response in COVID‐19 patients by symptoms grade, gender, age, BMI, and medication. Journal of Medical Virology, 94(4), 1412–1418.
Parisi, G. F., Diaferio, L., Brindisi, G., Indolfi, C., Umano, G. R., Klain, A., Marchese, G., Ghiglioni, D. G., Zicari, A. M., & Marseglia, G. L. (2021). Cross-sectional survey on long term sequelae of pediatric COVID-19 among Italian pediatricians. Children, 8(9), 769.
Simani, L., Ramezani, M., Darazam, I. A., Sagharichi, M., Aalipour, M. A., Ghorbani, F., & Pakdaman, H. (2021). Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. Journal of Neurovirology, 27, 154–159.
Sivan, M., & Taylor, S. (2020). NICE guideline on long covid. In bmj (Vol. 371). British Medical Journal Publishing Group.
Stewart, S., Newson, L., Briggs, T. A., Grammatopoulos, D., Young, L., & Gill, P. (2021). Long COVID risk-a signal to address sex hormones and women’s health. The Lancet Regional Health–Europe, 11.
Sudre, C. H., Murray, B., Varsavsky, T., Graham, M. S., Penfold, R. S., Bowyer, R. C., Pujol, J. C., Klaser, K., Antonelli, M., & Canas, L. S. (2021). Author Correction: Attributes and predictors of long COVID. Nature Medicine, 27(6), 1116.
Sykes, D. L., Holdsworth, L., Jawad, N., Gunasekera, P., Morice, A. H., & Crooks, M. G. (2021). Post- COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung, 199, 113–119.
Sylvester, S. V, Rusu, R., Chan, B., Bellows, M., O’Keefe, C., & Nicholson, S. (2022). Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Current Medical Research and Opinion, 38(8), 1391–1399.
Taquet, M., Dercon, Q., Luciano, S., Geddes, J. R., Husain, M., & Harrison, P. J. (2021). Incidence, co- occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Medicine, 18(9), e1003773.
Tenforde, M. W., Kim, S. S., Lindsell, C. J., Rose, E. B., Shapiro, N. I., Files, D. C., Gibbs, K. W., Erickson, H. L., Steingrub, J. S., & Smithline, H. A. (2020). Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March–June 2020. Morbidity and Mortality Weekly Report, 69(30), 993.
Yong, S. J. (2021). Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infectious Diseases, 53(10), 737–754.
Ziauddeen, N., Gurdasani, D., O’Hara, M. E., Hastie, C., Roderick, P., Yao, G., & Alwan, N. A. (2022). Characteristics and impact of Long Covid: Findings from an online survey. PloS One, 17(3), e0264331.
